Haisco Pharmaceutical Group (002653.SZ) plans to establish wholly-owned subsidiaries in the British Virgin Islands and the Cayman Islands respectively.
Hisilicon (002653.SZ) issued an announcement that the 18th meeting of the fifth Board of Directors approved the "About..." document.
Haisco Pharmaceutical Group (002653.SZ) announced that the 18th meeting of the fifth board of directors approved the proposal to establish wholly-owned subsidiaries in the British Virgin Islands and Cayman Islands. The company has agreed to establish a wholly-owned subsidiary named HEXGEN HOLDINGS LIMITED in the British Virgin Islands and a wholly-owned subsidiary named HEXGEN PHARMACEUTICAL GROUP LIMITED (proposed name, Chinese name: Haisco Jin Pharmaceutical Group Limited) in Cayman Islands.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
